These findings, in combination with the lack of burden of LoF variants in TNNI3K in patients with DCM, suggest that LoF variants may not be pathogenic, although this will require further study given currently the small numbers of homozygous carriers. This evidence concerns the gene TNNI3K and familial dilated cardiomyopathy.